Bone Density Test Market Information: By Type (Central Dual-Energy X-Ray Absorptiometry (DXA), Radiographic Absorptiometry), Indication (Osteoporosis, Hyperthyroidism,), Device (Central DEXA Scan Machine), End User (Hospitals) - Global Forecast Till 2027

Market Synopsis of the Global Bone Density Test Market

Bone density test determines the density of bones and chances of the bone being broken. Central dual-energy X-ray absorptiometry (DXA) test is recommended for testing the bone density of hip and spine. Bone density test used in the diagnosis of osteoporosis, and osteopenia. The osteoporosis mostly occurs in women after the menopause but may also be present in males. The condition is less common in adults and children.

Rising prevalence of osteoporosis, osteopenia, hyperthyroidism, and increasing demand for portable bone testing devices drive the market growth. Furthermore, the demand for diagnosis and treatment measures for osteoporosis also influence the market growth. Additionally, the demand for technologically advanced devices drives the market growth.

According to the International Osteoporosis Foundation, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds across the globe. It also stated that osteoporosis affected an estimated 75 million people in Europe, the US, and Japan.

The global bone density test market is expected to grow at a CAGR of 7.2% during the forecast period.

FIGURE 1: Global Bone Density Test Market by Region, 2016 (%)

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Key Players in the Global Bone Density Test Market    

Some of the key players in this market are General Electric Company (U.S.), Hologic Inc. (U.S), BeamMed Ltd.  (Israel), Swissray (U.S.), Osteosys Corp (South Korea), DMS Imaging (France), Medonica Co. LLTb (South KOrea), Osteometer Meditech Inc. (U.S), and Lone Oak Medical Technologies, LLC (U.S.)

Segments

The global bone density test market is segmented on the basis of type, indication, devices, and end user.

On the basis of the type, the market is segmented into Central dual-energy x-ray absorptiometry (DXA), peripheral tests, radiographic absorptiometry, and others.

 Peripheral tests is further segmented into peripheral dual energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), and peripheral quantitative computed tomography (pQCT).

On the basis of the indication, the market is segmented into osteoporosis, osteopenia, hyperthyroidism, hyperparathyroidism, and others.

On the basis of devices, the market is segmented into central DEXA scan machine and hand held devices.

On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.

Research Methodology 

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Regional Analysis of the Global Bone Density Test Market

The Americas hold the first position in global bone density test market owing to the rising prevalence of osteoporosis and other bone disorders, and increasing demand for hand held devices for bone density test. The prevalence of osteoporosis is found to be higher in the population over 35 years of age. Changing lifestyle, emphasis on fitness and exercise, and overall development of medical device industry also accelerate the growth of the market.

Europe is the second largest market for bone density test. In European countries the prevalence of osteoporosis has been increasing from the last few years. Furthermore, increasing demand for portable and hand held devices for the diagnosis of osteoporosis and osteopenia add fuel to the growth of the market. However, changing population demographics likely to affect the prevalence of osteoporosis in the European Union (EU).

The Asia Pacific market is expected to grow rapidly and is driven by the rising prevalence of osteoporosis in women after menopause. Additionally, increasing awareness regarding women healthcare and nutrition also influence the market growth. Japan is the largest bone density test market in Asia Pacific region. Rising healthcare expenditure, and extensive growth of medical device industry also boost the demand for the medical devices for diagnosis of various diseases such as osteoporosis, diabetes, cancer, and others.

The Middle East & Africa also show a steady rise in the market owing to low demand for the bone density tests than the developed nations, and emphasis on primary care services.

Intended Audience

• Drug Manufacturers


• Drug Suppliers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

Frequently Asked Questions (FAQ) :

---